These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29489874)

  • 1. Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016.
    Khan A; Fahl Mar K; Schilling J; Brown WA
    PLoS One; 2018; 13(2):e0193043. PubMed ID: 29489874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the increasing placebo response impact outcomes of adult and pediatric ADHD clinical trials? Data from the US Food and Drug Administration 2000-2009.
    Khan A; Fahl Mar K; Brown WA
    J Psychiatr Res; 2017 Nov; 94():202-207. PubMed ID: 28755620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and pattern of placebo response in clinical trials of antiepileptic medications: Data from the Food and Drug Administration 1996-2016.
    Khan A; Fahl Mar K; Schilling J; Brown WA
    Contemp Clin Trials; 2018 Jan; 64():95-100. PubMed ID: 29101042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude and Pattern of Placebo Response in Clinical Trials of Oral Antihyperglycemic Agents: Data From the U.S. Food and Drug Administration, 1999-2015.
    Khan A; Fahl Mar K; Schilling J; Brown WA
    Diabetes Care; 2018 May; 41(5):994-1000. PubMed ID: 29363537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2012 Jun; 73(6):856-64. PubMed ID: 22687813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013.
    Khan A; Fahl Mar K; Faucett J; Khan Schilling S; Brown WA
    World Psychiatry; 2017 Jun; 16(2):181-192. PubMed ID: 28498591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration.
    Gopalakrishnan M; Zhu H; Farchione TR; Mathis M; Mehta M; Uppoor R; Younis I
    J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32141721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration.
    Borges S; Chen YF; Laughren TP; Temple R; Patel HD; David PA; Mathis M; Unger E; Yang P; Khin NA
    J Clin Psychiatry; 2014 Mar; 75(3):205-14. PubMed ID: 24717376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
    Neaton JD; Grimm RH; Prineas RJ; Stamler J; Grandits GA; Elmer PJ; Cutler JA; Flack JM; Schoenberger JA; McDonald R
    JAMA; 1993 Aug; 270(6):713-24. PubMed ID: 8336373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy.
    Waeber B; Brunner HR
    Blood Press Monit; 1999 Oct; 4(5):263-6. PubMed ID: 10547648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig JG; Schunkert H; Taylor AA; Boye S; Jin J; Keefe DL
    Clin Ther; 2009 Dec; 31(12):2839-50. PubMed ID: 20110023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies.
    Briasoulis A; Agarwal V; Tousoulis D; Stefanadis C
    Heart; 2014 Feb; 100(4):317-23. PubMed ID: 23813846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.